These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12014818)

  • 1. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington.
    French MT; Salomé HJ; Krupski A; McKay JR; Donovan DM; McLellan AT; Durell J
    Eval Rev; 2000 Dec; 24(6):609-34. PubMed ID: 11151519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.
    Beattie MC; Hu TW; Li R; Bond JC
    J Behav Health Serv Res; 2005; 32(4):409-29. PubMed ID: 16215450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Client outcomes from rural substance abuse treatment.
    Hiller ML; Leukefeld CG; Garrity TF; Godlaski T; Schoeneberger M; Townsend M; Hascal K
    J Psychoactive Drugs; 2007 Mar; 39(1):59-68. PubMed ID: 17523586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
    Goodman AC; Nishiura E; Humphreys RS
    Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incentives in a public addiction treatment system: Effects on waiting time and selection.
    Stewart MT; Reif S; Dana B; Nguyen A; Torres M; Davis MT; Ritter G; Hodgkin D; Horgan CM
    J Subst Abuse Treat; 2018 Dec; 95():1-8. PubMed ID: 30352665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of centralized intake on outcomes of substance abuse treatment.
    Rohrer JE; Vaughan MS; Cadoret RJ; Carswell C; Patterson A; Zwick J
    Psychiatr Serv; 1996 Nov; 47(11):1233-8. PubMed ID: 8916242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.
    Lee MT; Acevedo A; Garnick DW; Horgan CM; Panas L; Ritter GA; Campbell KM
    Psychiatr Serv; 2018 Jul; 69(7):804-811. PubMed ID: 29695226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems in the application of the Addiction Severity Index (ASI) in rural substance abuse services.
    Wertz JS; Cleaveland BL; Stephens RS
    J Subst Abuse; 1995; 7(2):175-88. PubMed ID: 7580228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes.
    J Stud Alcohol; 1997 Jan; 58(1):7-29. PubMed ID: 8979210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in alcoholism treatment.
    Schmidt L; Weisner C
    Recent Dev Alcohol; 1993; 11():369-96. PubMed ID: 8234931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.
    Sindelar JL; Jofre-Bonet M; French MT; McLellan AT
    Drug Alcohol Depend; 2004 Jan; 73(1):41-50. PubMed ID: 14687958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of regular vs. extended alcohol/drug outpatient treatment: I. Relapse, aftercare, and treatment re-entry.
    Kamara SG; Van Der Hyde VA
    Med Law; 1997; 16(3):607-20. PubMed ID: 9409140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.
    Parthasarathy S; Weisner C; Hu TW; Moore C
    J Stud Alcohol; 2001 Jan; 62(1):89-97. PubMed ID: 11271969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidimensional impact of treatment for substance abuse.
    Hoffmann NG; Harrison PA; Belille CA
    Adv Alcohol Subst Abuse; 1984; 3(3):83-94. PubMed ID: 6496235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.